Psychometric evaluation of the EORTC computerized adaptive test (CAT) fatigue item pool.

PubWeight™: 0.85‹?›

🔗 View Article (PMID 23446449)

Published in Qual Life Res on February 28, 2013

Authors

Morten Aa Petersen1, Johannes M Giesinger, Bernhard Holzner, Juan I Arraras, Thierry Conroy, Eva-Maria Gamper, Madeleine T King, Irma M Verdonck-de Leeuw, Teresa Young, Mogens Groenvold

Author Affiliations

1: The Research Unit, Department of Palliative Medicine, Bispebjerg University Hospital, Bispebjerg bakke 23, 2400, Copenhagen, NV, Denmark, mpet0009@bbh.regionh.dk.

Articles by these authors

Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2. J Clin Oncol (2010) 7.29

Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol (2006) 7.05

Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol (2007) 6.08

Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. J Clin Oncol (2011) 4.77

Quality of life three years after diagnosis of localised prostate cancer: population based cohort study. BMJ (2009) 3.58

XELOX (capecitabine plus oxaliplatin): active first-line therapy for patients with metastatic colorectal cancer. J Clin Oncol (2004) 3.10

Impact of FOLFIRINOX compared with gemcitabine on quality of life in patients with metastatic pancreatic cancer: results from the PRODIGE 4/ACCORD 11 randomized trial. J Clin Oncol (2012) 2.92

Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: final analysis of the randomized UNICANCER ACCORD 03 trial. J Clin Oncol (2012) 2.62

Caring for Aged Dementia Care Resident Study (CADRES) of person-centred care, dementia-care mapping, and usual care in dementia: a cluster-randomised trial. Lancet Neurol (2009) 2.38

Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy. J Clin Oncol (2008) 2.23

Development of the European Organisation for Research and Treatment of Cancer quality of life questionnaire module for older people with cancer: The EORTC QLQ-ELD15. Eur J Cancer (2010) 2.20

The development of the EORTC QLQ-C15-PAL: a shortened questionnaire for cancer patients in palliative care. Eur J Cancer (2005) 1.97

Randomized controlled trial of the role of positron emission tomography in the management of stage I and II non-small-cell lung cancer. J Clin Oncol (2004) 1.86

Clinical outcome of the ACCORD 12/0405 PRODIGE 2 randomized trial in rectal cancer. J Clin Oncol (2012) 1.74

Patient-reported outcome results from the open-label phase III AURELIA trial evaluating bevacizumab-containing therapy for platinum-resistant ovarian cancer. J Clin Oncol (2014) 1.69

Evidence-based guidelines for determination of sample size and interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. J Clin Oncol (2010) 1.68

Advanced breast cancer patients' perceptions of decision making for palliative chemotherapy. J Clin Oncol (2006) 1.67

Fatigue and physical function after orthotopic liver transplantation. Liver Transpl (2002) 1.61

Comparing higher order models for the EORTC QLQ-C30. Qual Life Res (2011) 1.60

Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOX-6) as first-line treatment for metastatic colorectal cancer. Int J Cancer (2011) 1.51

Quality of life in patients with diffuse large B-cell lymphoma treated with dose-dense chemotherapy is only affected temporarily. Leuk Lymphoma (2011) 1.47

Economic evaluation of a randomised trial of early return to normal activities versus cardiac rehabilitation after acute myocardial infarction. Heart Lung Circ (2002) 1.40

Age, health, and education determine supportive care needs of men younger than 70 years with prostate cancer. J Clin Oncol (2007) 1.34

Time trade-off derived EQ-5D weights for Australia. Value Health (2011) 1.33

The "forgotten joint" as the ultimate goal in joint arthroplasty: validation of a new patient-reported outcome measure. J Arthroplasty (2011) 1.32

Predictive modelling for swallowing dysfunction after primary (chemo)radiation: results of a prospective observational study. Radiother Oncol (2011) 1.31

Quality of life among disease-free survivors of rectal cancer. J Clin Oncol (2004) 1.30

A predictive model for swallowing dysfunction after curative radiotherapy in head and neck cancer. Radiother Oncol (2009) 1.28

Use of differential item functioning analysis to assess the equivalence of translations of a questionnaire. Qual Life Res (2003) 1.27

Quality of life in patients with benign thyroid disorders. A review. Eur J Endocrinol (2006) 1.25

Quality of life and functional status in patients with cancer of the oral cavity and oropharynx: pretreatment values of a prospective study. Eur Arch Otorhinolaryngol (2007) 1.24

Quality of life in long-term survivors of oropharynx carcinoma. Int J Radiat Oncol Biol Phys (2002) 1.23

Assessing health-related quality of life in palliative care: comparing patient and physician assessments. Eur J Cancer (2006) 1.22

What influences participation in genetic carrier testing? Results from a discrete choice experiment. J Health Econ (2005) 1.22

Multidimensional computerized adaptive testing of the EORTC QLQ-C30: basic developments and evaluations. Qual Life Res (2006) 1.22

Effectiveness of aromatherapy massage in the management of anxiety and depression in patients with cancer: a multicenter randomized controlled trial. J Clin Oncol (2007) 1.21

The Computer-based Health Evaluation Software (CHES): a software for electronic patient-reported outcome monitoring. BMC Med Inform Decis Mak (2012) 1.20

Deriving a preference-based measure for cancer using the EORTC QLQ-C30. Value Health (2011) 1.20

Does a patient's self-reported health-related quality of life predict survival beyond key biomedical data in advanced colorectal cancer? Eur J Cancer (2005) 1.20

Health related quality of life in a nationally representative sample of haematological patients. Eur J Haematol (2009) 1.20

Longitudinal study of sexual function and vaginal changes after radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys (2003) 1.16

Implementation of computer-based quality-of-life monitoring in brain tumor outpatients in routine clinical practice. J Pain Symptom Manage (2010) 1.15

Early-stage cervical carcinoma, radical hysterectomy, and sexual function. A longitudinal study. Cancer (2004) 1.14

Quality of life and survival in the 2 years after surgery for non small-cell lung cancer. J Clin Oncol (2007) 1.13

Designs and challenges for personalized medicine studies in oncology: focus on the SHIVA trial. Target Oncol (2012) 1.13

Is the toxicity of adjuvant aromatase inhibitor therapy underestimated? Complementary information from patient-reported outcomes (PROs). Breast Cancer Res Treat (2011) 1.13

The psychometric and clinical validity of the SWAL-QOL questionnaire in evaluating swallowing problems experienced by patients with oral and oropharyngeal cancer. Oral Oncol (2009) 1.12

Swallowing dysfunction in cancer patients. Support Care Cancer (2011) 1.12

Self-assessment in cancer patients referred to palliative care: a study of feasibility and symptom epidemiology. Cancer (2002) 1.12

A simulation study provided sample size guidance for differential item functioning (DIF) studies using short scales. J Clin Epidemiol (2008) 1.12

Health status and voice outcome after treatment for T1a glottic carcinoma. Eur Arch Otorhinolaryngol (2004) 1.11

Differential item functioning (DIF) analyses of health-related quality of life instruments using logistic regression. Health Qual Life Outcomes (2010) 1.11

Quality of life after surgical treatment for oral and oropharyngeal cancer: a prospective longitudinal assessment of patients reconstructed by a microvascular flap. Oral Oncol (2007) 1.10

Does mode of administration matter? Comparison of online and face-to-face administration of a time trade-off task. Qual Life Res (2010) 1.10

Predictive factors of positive circumferential resection margin after radiochemotherapy for rectal cancer: the French randomised trial ACCORD12/0405 PRODIGE 2. Eur J Cancer (2012) 1.10

A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites. Cancer (2013) 1.10

Psychological morbidity and quality of life of ethnic minority patients with cancer: a systematic review and meta-analysis. Lancet Oncol (2011) 1.09

Responsiveness of EORTC QLQ-C30, QLQ-CR38 and FACT-C quality of life questionnaires in patients with colorectal cancer. Health Qual Life Outcomes (2011) 1.08

A review and recommendations for optimal outcome measures of anxiety, depression and general distress in studies evaluating psychosocial interventions for English-speaking adults with heterogeneous cancer diagnoses. Support Care Cancer (2010) 1.08

Quality, interpretation and presentation of European Organisation for Research and Treatment of Cancer quality of life questionnaire core 30 data in randomised controlled trials. Eur J Cancer (2008) 1.07

The efficacy of voice therapy in patients after treatment for early glottic carcinoma. Cancer (2006) 1.07

Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-OG25, to assess health-related quality of life in patients with cancer of the oesophagus, the oesophago-gastric junction and the stomach. Eur J Cancer (2007) 1.07

Normative data for the EORTC QLQ-C30 and EORTC-sexuality items in the general Dutch population. Eur J Cancer (2010) 1.06

Validation of modified forms of the PedsQL generic core scales and cancer module scales for adolescents and young adults (AYA) with cancer or a blood disorder. Qual Life Res (2009) 1.04

Cordectomy by CO2 laser or radiotherapy for small T1a glottic carcinomas: costs, local control, survival, quality of life, and voice quality. Head Neck (2007) 1.04

Development of a questionnaire to evaluate the information needs of cancer patients: the EORTC questionnaire. Patient Educ Couns (2004) 1.04

An international validation study of the EORTC QLQ-INFO25 questionnaire: an instrument to assess the information given to cancer patients. Eur J Cancer (2010) 1.03

Prospective evaluation of voice outcome during the first two years in male patients treated by radiotherapy or laser surgery for T1a glottic carcinoma. Eur Arch Otorhinolaryngol (2012) 1.03

Giving meaning to measure: linking self-reported fatigue and function to performance of everyday activities. J Pain Symptom Manage (2006) 1.03

Taste alterations in cancer patients receiving chemotherapy: a neglected side effect? Oncologist (2010) 1.02

Development of computerised adaptive testing (CAT) for the EORTC QLQ-C30 dimensions - general approach and initial results for physical functioning. Eur J Cancer (2010) 1.02

Development of an EORTC quality of life phase III module measuring cancer-related fatigue (EORTC QLQ-FA13). Psychooncology (2012) 1.01

Validity and reliability of the novel thyroid-specific quality of life questionnaire, ThyPRO. Eur J Endocrinol (2009) 1.01

Prospective evaluation of health-related quality of life in long-term oral and oropharyngeal cancer survivors and the perceived need for supportive care. Oral Oncol (2013) 1.01

A single-arm phase II Austrian/German multicenter trial on continuous daily sunitinib in primary glioblastoma at first recurrence (SURGE 01-07). Neuro Oncol (2013) 1.01

Improving a newly developed patient-reported outcome for thyroid patients, using cognitive interviewing. Qual Life Res (2008) 1.00

Speech Handicap Index in patients with oral and pharyngeal cancer: better understanding of patients' complaints. Head Neck (2008) 0.99

Health-related quality of life assessment and reported outcomes in leukaemia randomised controlled trials - a systematic review to evaluate the added value in supporting clinical decision making. Eur J Cancer (2008) 0.99

Health-related quality of life in long-term breast cancer survivors: nationwide survey in Denmark. Breast Cancer Res Treat (2006) 0.99

The relationship between overall quality of life and its subdimensions was influenced by culture: analysis of an international database. J Clin Epidemiol (2008) 0.98

EORTC QLQ-INFO26: a questionnaire to assess information given to cancer patients a preliminary analysis in eight countries. Psychooncology (2007) 0.98

Validity, responsiveness, and minimal important difference for the SF-6D health utility scale in a spinal cord injured population. Value Health (2008) 0.98

Improving access to supportive cancer care through an eHealth application: a qualitative needs assessment among cancer survivors. J Clin Nurs (2015) 0.98

Construct validity of a revised Physical Activity Scale and testing by cognitive interviewing. Scand J Public Health (2010) 0.97

More than 10% weight loss in head and neck cancer patients during radiotherapy is independently associated with deterioration in quality of life. Nutr Cancer (2013) 0.97

Quality of life in adult hematopoietic cell transplant patients at least 5 yr after treatment: a comparison with healthy controls. Eur J Haematol (2005) 0.97

Are different groups of cancer patients offered rehabilitation to the same extent? A report from the population-based study "The Cancer Patient's World". Support Care Cancer (2011) 0.96

Psychomotor car-driving abilities after robotically assisted totally endoscopic coronary artery bypass grafting. Thorac Cardiovasc Surg (2012) 0.96

Quality of life trajectory in patients with advanced cancer during the last year of life. J Palliat Med (2011) 0.94

An Australian discrete choice experiment to value eq-5d health states. Health Econ (2013) 0.94

Capecitabine/oxaliplatin, a safe and active first-line regimen for older patients with metastatic colorectal cancer: post hoc analysis of a large phase II study. Clin Colorectal Cancer (2005) 0.93

Health status rated with the Medical Outcomes Study 36-Item Short-Form Health Survey after spinal cord injury. Arch Phys Med Rehabil (2005) 0.93